For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online
United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    Proteins and Peptides
    By product type
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex miRNA assays
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Customized Products & Partnerships
    Customized Products & Partnerships

    Customized products and commercial partnerships to accelerate your diagnostic and therapeutic programs.

    Customized products

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

Epithelial to mesenchymal transition tools

Related

  • EMT resources
    • Vimentin toolbox
      • EMT in heart development
        • Webinar: Epithelial to Mesenchymal Transition in Carcinoma
          • E-cadherin research tools
            • N-cadherin research tools
              • EMT (Beta Catenin, Vimentin) western blot cocktail (ab157392)
                • EMT marker panel (ab216833)
                    • Oncology resources
                      • Cancer biomarkers guide
                        • Biomarkers of metastasis
                          • Choosing metastasis antibodies
                            • Studying hallmarks of cancer

                              Your guide to EMT markers in cancer. 

                              Activation of epithelial to mesenchymal transition (EMT) is a key process in cancer cell metastasis, during which epithelial cells acquire mesenchymal characteristics with an enhancement of cell motility and migration.

                              EMT is characterised by a loss of epithelial cell markers, such as cytokeratins and E-cadherin, followed by an upregulation in the expression of mesenchymal cell markers, such as N-cadherin, vimentin, and fibronectin. 

                              These epithelial and mesenchymal cell marker expression changes lead to a reduction in adhesion between the transitioning cell and adjacent epithelial cells, and an increase in the secretion of enzymes that degrade the extracellular matrix.1 Collectively, this results in epithelial cells losing apical-basal cell polarity, reorganizing their cytoskeleton, and reprogramming gene expression; enabling the development of an invasive phenotype in cancer metastasis.2 

                              Contents:

                              • E-cadherin
                              • N-cadherin
                              • Vimentin
                              • SNAIL

                              E-Cadherin

                              Decreased E-cadherin expression is a fundamental event in EMT and cancer metastasis and has emerged as a molecular hallmark of the carcinoma EMT.​3 

                              Cytoskeletal modification
                              As epithelial cells become mesenchymal cells, cytoskeletal changes occur that promote cell motility. Actin stress fibers form and the intermediate filament composition shifts with the repression of cytokeratin and the upregulation of vimentin expression.

                              We recommend Recombinant Anti-E Cadherin antibody [EP700Y] (ab40772)

                              Image (above): Immunohistochemistry (formalin/PFA-fixed paraffin-embedded sections) of human breast carcinoma tissue stained using Recombinant Anti-E cadherin antibody [EP700Y] (ab40772) (green).

                              Browse all E-cadherin antibodies


                              N-cadherin

                              The loss of E-cadherin is typically associated with a gain of expression of the mesenchymal marker, N-cadherin, in many cancer types and is thought to be necessary for tumor cells to gain invasive properties.4

                              We recommend Anti-N Cadherin antibody (ab18203)
                              Image (above): Immunohistochemistry (formalin/PFA-fixed paraffin-embedded sections) of human liver cancer tissue stained with Anti-N Cadherin antibody (ab18203).

                              Browse all N-cadherin antibodies


                              Vimentin

                              Overexpression of vimentin is correlated with increased invasiveness and metastasis of several cancers.5

                                ​We recommend Recombinant Anti-Vimentin antibody [EPR3776] (ab92547). 

                                Image (above): Immunohistochemistry (formalin/PFA-fixed paraffin-embedded sections) of human breast adenocarcinoma tissue stained using Recombinant Anti-Vimentin antibody [EPR3776] (ab92547). ​

                                Browse all vimentin antibodies.


                                SNAIL

                                ​The change in the epithelial and mesenchymal gene expression that occurs during EMT is regulated by multiple transcription factor families that include SNAI1/Snail, ZEB1/ZEB2, and basic helix-loop-helix transcription factors (bHLH).​2

                                ​​We recommend Anti-SNAIL + SLUG antibody (ab180714). 

                                Image (above): Immunohistochemistry (formalin/PFA-fixed paraffin-embedded sections) of human cervical carcinoma tissue stained with Recombinant Anti-ZEB1(AREB6) antibody (ab203829).

                                Browse all SNAIL and SLUG antibodies

                                Browse all ZEB1/AREB6 antibodies

                                Browse all ZEB2/SIP1 antibodies


                                Couldn't find what you were looking for?

                                View all our relevant EMT products or find out more about how we can support your project with customized proteomic reagents and assays.



                                ​References

                                1. ​​Banyard, J. and Bielenberg, D. R. Connect Tissue Res. 2015; 56(5):403–413.
                                2. Lamouille, S., Xu, J., & Derynck, R. Nature Rev: Mol Cell Biol. 2014; 15(3), 178–196.
                                3. Wells, A. et al. Clin & Exper Metastasis. 2008; 25(6), 621–628. 
                                4. Jia, W. et al. Anticancer Res. 2015; 35 (5), 2635-2643.
                                5. Vergara, D. et al. EuPA Open Proteomics. 2016; 10, 31-41.


                                Get resources and offers direct to your inbox Sign up
                                A-Z by research area
                                • Cancer
                                • Cardiovascular
                                • Cell biology
                                • Developmental biology
                                • Epigenetics & Nuclear signaling
                                • Immunology
                                • Metabolism
                                • Microbiology
                                • Neuroscience
                                • Signal transduction
                                • Stem cells
                                A-Z by product type
                                • Primary antibodies
                                • Secondary antibodies
                                • Biochemicals
                                • Isotype controls
                                • Flow cytometry multi-color selector
                                • Kits
                                • Loading controls
                                • Lysates
                                • Peptides
                                • Proteins
                                • Slides
                                • Tags and cell markers
                                • Tools & Reagents
                                Help & support
                                • Support
                                • Make an Inquiry
                                • Protocols & troubleshooting
                                • Placing an order
                                • RabMAb products
                                • Biochemical product FAQs
                                • Training
                                • Browse by Target
                                Company
                                • Corporate site
                                • Investor relations
                                • Company news
                                • Careers
                                • About us
                                • Blog
                                Events
                                • Tradeshows
                                • Conferences
                                International websites
                                • abcam.cn
                                • abcam.co.jp

                                Join with us

                                • LinkedIn
                                • facebook
                                • Twitter
                                • YouTube
                                • Terms of sale
                                • Website terms of use
                                • Cookie policy
                                • Privacy policy
                                • Legal
                                • Modern slavery statement
                                © 1998-2022 Abcam plc. All rights reserved.